TY - JOUR
T1 - Effect of antioxidants on hyperoxia-induced ICAM-1 expression in human endothelial cells
AU - Aoki, Takuya
AU - Suzuki, Yukio
AU - Nishio, Kazumi
AU - Suzuki, Kouichi
AU - Miyata, Atsushi
AU - Oyamada, Yoshitaka
AU - Mori, Masaaki
AU - Fujita, Hirofumi
AU - Yamaguchi, Kazuhiro
PY - 1997/1/1
Y1 - 1997/1/1
N2 - The regulating mechanism of hyperoxia-induced ICAM-1 expression has not been elucidated. We studied the effect of antioxidants, including superoxide dismutase (SOD), catalase and N-acetylcysteine (NAC), on hyperoxia-induced ICAM-1 expression in human pulmonary artery endothelial cells (HPAEC) and human umbilical vein endothelial cells (HUVEC). Cells were cultured to confluence and exposed to either hyperoxic or normoxic gas with or without various kinds of antioxidants. The levels of ICAM-1 expression in the endothelial cells and the concentrations of reduced (GSH) and oxidized glutathione (GSSG) in the media were examined by flow cytometry spectrophotometry, respectively. After 48-hour exposure to hyperoxia, ICAM-1 expression was increased HPAEC; 161 ± 21% and HUVEC; 163 ± 16%) and total glutathione concentration in the media was decreased as compared with normoxia. SOD did not change the GSH and GSSG concentrations in the media. Catalase dose-dependently decreased the supernatant GSSG concentration in both HPAEC and HUVEC, while the GSH concentration was nearly constant. NAC dose-dependently increased the supernatant GSH concentrations in both HPAEC and HUVEC. There was no difference in the supernatant GSSG concentrations between the NAC-treated HPAEC and HUVEC. There was no difference in ICAM-1 expression in either HPAEC or HUVEC with SOD treatment. ICAM-1 expressions in 100 U/ml (236 ± 20%) and 1,000 U/ml (315 ± 36%) of catalase were increased in HPAEC, and that in 1,000 U/ml (440 ± 209%) of catalase was increased in HUVEC. Five and 10 U/ml of NAC decreased ICAM-1 expression in HPAEC (141 ± 26% and 113 ± 11%) and HUVEC (119 ± 23% and 106 ± 7%), respectively. These results suggest that extracellular glutathione may play a role in regulating hyperoxia-induced ICAM-1 expression in HPAEC and HUVEC.
AB - The regulating mechanism of hyperoxia-induced ICAM-1 expression has not been elucidated. We studied the effect of antioxidants, including superoxide dismutase (SOD), catalase and N-acetylcysteine (NAC), on hyperoxia-induced ICAM-1 expression in human pulmonary artery endothelial cells (HPAEC) and human umbilical vein endothelial cells (HUVEC). Cells were cultured to confluence and exposed to either hyperoxic or normoxic gas with or without various kinds of antioxidants. The levels of ICAM-1 expression in the endothelial cells and the concentrations of reduced (GSH) and oxidized glutathione (GSSG) in the media were examined by flow cytometry spectrophotometry, respectively. After 48-hour exposure to hyperoxia, ICAM-1 expression was increased HPAEC; 161 ± 21% and HUVEC; 163 ± 16%) and total glutathione concentration in the media was decreased as compared with normoxia. SOD did not change the GSH and GSSG concentrations in the media. Catalase dose-dependently decreased the supernatant GSSG concentration in both HPAEC and HUVEC, while the GSH concentration was nearly constant. NAC dose-dependently increased the supernatant GSH concentrations in both HPAEC and HUVEC. There was no difference in the supernatant GSSG concentrations between the NAC-treated HPAEC and HUVEC. There was no difference in ICAM-1 expression in either HPAEC or HUVEC with SOD treatment. ICAM-1 expressions in 100 U/ml (236 ± 20%) and 1,000 U/ml (315 ± 36%) of catalase were increased in HPAEC, and that in 1,000 U/ml (440 ± 209%) of catalase was increased in HUVEC. Five and 10 U/ml of NAC decreased ICAM-1 expression in HPAEC (141 ± 26% and 113 ± 11%) and HUVEC (119 ± 23% and 106 ± 7%), respectively. These results suggest that extracellular glutathione may play a role in regulating hyperoxia-induced ICAM-1 expression in HPAEC and HUVEC.
UR - http://www.scopus.com/inward/record.url?scp=0030743968&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030743968&partnerID=8YFLogxK
U2 - 10.1007/978-1-4615-5865-1_63
DO - 10.1007/978-1-4615-5865-1_63
M3 - Article
C2 - 9269467
AN - SCOPUS:0030743968
SN - 0065-2598
VL - 411
SP - 503
EP - 511
JO - Advances in experimental medicine and biology
JF - Advances in experimental medicine and biology
ER -